HIV vaccine recruitment was aided by community outreach program

June 2009
Clinical Trials Administrator;Jun2009, Vol. 7 Issue 6, p68
The article focuses on a study which examines the application of an HIV vaccine recruitment strategy to a minority community in the U.S. According to Paula Frew, assistant professor of medicine in infectious disease at the School of Medicine and Rollins School of Public Health of Emory University in Atlanta, Georgia, the strategy used by the clinical trial site included a community advocacy board (CAB) involved in a dialogue with CT personnel. Frew claims that the recruitment of minorities could have long-term implications.


Related Articles

  • Cold shower for AIDS vaccines.  // Nature Medicine;Dec2007, Vol. 13 Issue 12, p1389 

    The author reflects on the goal of developing AIDS vaccines that remains out of reach. He highlights the fact that HIV mutates in response to drugs, it mutates in response to immune pressure, it co-opts multiple cellular pathways to evade detection or destruction, it hides in reservoirs, and,...

  • Rational design of HIV vaccine and microbicides: report of the EUROPRISE annual conference. Wahren, Britta; Biswas, Priscilla; Borggren, Marie; Coleman, Adam; Da Costa, Kelly; De Haes, Winni; Dieltjens, Tessa; Dispinseri, Stefania; Grupping, Katrijn; Hallengärd, David; Hornig, Julia; Klein, Katja; Mainetti, Lara; Palma, Paolo; Reudelsterz, Marc; Seifried, Janna; Selhorst, Philippe; Sköld, Annette; van Gils, Marit J.; Weber, Caroline // Journal of Translational Medicine;2010, Vol. 8, p72 

    EUROPRISE is a Network of Excellence sponsored from 2007 to 2011 by the European Commission within the 6th Framework Program. The Network encompasses a wide portfolio of activities ranging from an integrated research program in the field of HIV vaccines and microbicides to training,...

  • The 2010 scientific strategic plan of the Global HIV Vaccine Enterprise. Berkley, Seth; Bertram, Kenneth; Delfraissy, Jean-François; Draghia-Akli, Ruxandra; Fauci, Anthony; Hallenbeck, Cynthia; Kagame, Madame Jeannette; Kim, Peter; Mafubelu, Daisy; Makgoba, Malegapuru W; Piot, Peter; Walport, Mark; Warren, Mitchell; Yamada, Tadataka; Esparza, José; Hankins, Catherine; Johnston, Margaret I.; Lévy, Yves; Romaris, Manuel; Ahmed, Rafi // Nature Medicine;Sep2010, Vol. 16 Issue 9, p981 

    The article focuses on the scientific strategic plan of Global HIV Vaccine Enterprise in 2010. It states that the Global HIV Vaccine Enterprise is a coalition of independent organizations which were committed to develop an HIV vaccine by making scientific strategic plan, increasing resources,...

  • What are the Current Advances Regarding HIV Vaccines and HIV Vaccine Trials? Dhalla, Shayesta // Journal of Bioanalysis & Biomedicine;2012, Vol. 4 Issue 3, p1 

    The author discusses the current advances on HIV vaccines around the world. She offers her views on the unsuccessful STEP study, a clinical trial which tested the efficacy of an HIV vaccine. The STEP study was stopped in 2007, which revealed an increase in HIV infection for the first 18 months...

  • CT site successfully recruited minorities for HIV vaccine study.  // Clinical Trials Administrator;Jun2009, Vol. 7 Issue 6, p69 

    The article deals with the enrollment of minorities for an HIV vaccine clinical trial (CT) in the U.S. It states that enrolling minorities in several HIV clinical trials is prioritized, particularly African Americans, because African Americans are disproportionately affected by the HIV/AIDS...

  • Patients support innovative models of care in recurrent genital herpes clinics: results from a patient satisfaction study. Hamill, M.; Goldmeier, D. // International Journal of STD & AIDS;Sep2005, Vol. 16 Issue 9, p615 

    Genital herpes is one of the most common sexually transmitted infections and is characterized by recurrent, painful, ulcerative lesions. Severe psychosocial disturbance has been described in a variety of settings and there are well-documented associations with poor self-esteem, centred around...

  • Phase I Trials of Preventive HIV/AIDS Vaccines Worldwide (August 2007).  // AIDS Alert;Oct2007, Vol. 22 Issue 10, p4 

    A list of Phase I trials of preventive HIV/AIDS vaccines worldwide, as of August 2007.

  • Researchers halt HIV vaccine trial -- What's the next step? Bower, Rebecca // AIDS Alert;Jan2008, Vol. 23 Issue 1, p8 

    The article reports on the cessation of an HIV vaccine clinical trial conducted by Merck & Co.

  • Some statistical issues in the design of HIV-1 vaccine and treatment trials. Gilbert, P.B. // Statistical Methods in Medical Research;Jun2000, Vol. 9 Issue 3, p207 

    This article summarizes material on statistical issues in the design of HIV-1 preventive vaccine trials and antiretroviral HIV-1 treatment trials that was presented at the first school on Modern Statistical Methods in Medical Research, held at the International Centre for Theoretical Physics in...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics